Combined treatment with RSV and doxorubicin has been shown to have synergistic effects on minimizing tumor growth and inhibiting cell migration via the suppression of EMT triggered by RSV through the control of the PTEN/Akt signaling pathway [123]. The gene discussed is AKT1; the disease is neoplasm.